PT100670A - Formulacoes farmaceuticas topicas de oleo-em -agua ou aquosa para o tratamento de infeccoes virais - Google Patents

Formulacoes farmaceuticas topicas de oleo-em -agua ou aquosa para o tratamento de infeccoes virais

Info

Publication number
PT100670A
PT100670A PT100670A PT10067092A PT100670A PT 100670 A PT100670 A PT 100670A PT 100670 A PT100670 A PT 100670A PT 10067092 A PT10067092 A PT 10067092A PT 100670 A PT100670 A PT 100670A
Authority
PT
Portugal
Prior art keywords
topical
treatment
water
aquosa
pharmaceutical formulations
Prior art date
Application number
PT100670A
Other languages
English (en)
Other versions
PT100670B (pt
Inventor
Hazel-Anne Griffiths
Alan John Goodall
Joshua Oduro-Yeboah
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PT100670A publication Critical patent/PT100670A/pt
Publication of PT100670B publication Critical patent/PT100670B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
PT100670A 1991-07-11 1992-07-09 Formulacoes farmaceuticas topicas de oleo-em -agua ou aquosa para o tratamento de infeccoes virais PT100670B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919114939A GB9114939D0 (en) 1991-07-11 1991-07-11 Pharmaceutical formulation

Publications (2)

Publication Number Publication Date
PT100670A true PT100670A (pt) 1993-10-29
PT100670B PT100670B (pt) 1999-07-30

Family

ID=10698164

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100670A PT100670B (pt) 1991-07-11 1992-07-09 Formulacoes farmaceuticas topicas de oleo-em -agua ou aquosa para o tratamento de infeccoes virais

Country Status (19)

Country Link
EP (1) EP0593562B1 (pt)
JP (1) JP2865867B2 (pt)
KR (1) KR100245016B1 (pt)
AT (1) ATE177638T1 (pt)
AU (2) AU2230792A (pt)
CA (1) CA2113080C (pt)
DE (1) DE69228686T2 (pt)
DK (1) DK0593562T3 (pt)
ES (1) ES2128353T3 (pt)
GB (1) GB9114939D0 (pt)
GR (1) GR3029886T3 (pt)
HK (1) HK1012242A1 (pt)
IE (1) IE922263A1 (pt)
MX (1) MX9204030A (pt)
NZ (1) NZ243490A (pt)
PT (1) PT100670B (pt)
TW (1) TW328049B (pt)
WO (1) WO1993000905A1 (pt)
ZA (1) ZA925130B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9326177D0 (en) * 1993-12-22 1994-02-23 Smithkline Beecham Plc Pharmaceuticals
US6124304A (en) * 1993-10-05 2000-09-26 Smithkline Beecham Plc Penciclovir for the treatment of zoster associated pain
IT1287114B1 (it) * 1996-10-31 1998-08-04 Recordati Chem Pharm Composizioni farmaceutiche antierpetiche per applicatori topici, contenenti aciclovir
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
GB9828620D0 (en) * 1998-12-23 1999-02-17 Glaxo Group Ltd Medicaments
CN109481674A (zh) * 2018-11-14 2019-03-19 大连亚维药业有限公司 一种生物无菌乳膏药物的生产方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8917959D0 (en) * 1989-08-05 1989-09-20 Beecham Group Plc Pharmaceutical formulation
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
AU2230792A (en) 1993-02-11
TW328049B (en) 1998-03-11
DE69228686D1 (de) 1999-04-22
ZA925130B (en) 1993-05-05
AU698847B2 (en) 1998-11-12
WO1993000905A1 (en) 1993-01-21
ATE177638T1 (de) 1999-04-15
HK1012242A1 (en) 1999-07-30
KR100245016B1 (ko) 2000-03-02
EP0593562A1 (en) 1994-04-27
ES2128353T3 (es) 1999-05-16
NZ243490A (en) 1995-03-28
CA2113080C (en) 2003-02-25
PT100670B (pt) 1999-07-30
GR3029886T3 (en) 1999-07-30
EP0593562B1 (en) 1999-03-17
GB9114939D0 (en) 1991-08-28
JP2865867B2 (ja) 1999-03-08
DK0593562T3 (da) 1999-09-27
CA2113080A1 (en) 1993-01-21
DE69228686T2 (de) 1999-09-09
AU4040195A (en) 1996-02-22
JPH06508845A (ja) 1994-10-06
MX9204030A (es) 1993-02-01
IE922263A1 (en) 1993-01-13

Similar Documents

Publication Publication Date Title
BR9810745A (pt) Derivados de benzimidazol
BR9713677A (pt) Formulações em gel para liberação tópica de droga
MY107843A (en) Anti-viral compounds.
ES2053429T3 (es) El uso de buspirona para la preparacion de composiciones farmaceuticas para aliviar la ansiedad fobica.
IT1216686B (it) Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
NO943837D0 (no) Terapeutisk aktive derivater av 1-naftylpyrazol-3-karboksamider, fremstilling av slike derivater, samt farmasöytiske preparater
PT100670A (pt) Formulacoes farmaceuticas topicas de oleo-em -agua ou aquosa para o tratamento de infeccoes virais
IT1230157B (it) Uso di sucralfato gel umido per il trattamento di ulcere del derma e come veicolo di farmaci ad attivita' topica
GR1001511B (el) Στεροειδείς συν?έσεις.
MY110074A (en) Pharmacuetical formulation.
BR9916043A (pt) Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
KR910004186A (ko) 제약학적 배합물
HUP9900945A2 (hu) Nukleozidanalógok herpes simplex vírus fertőzések kombinációs terápiájában
MX9303985A (es) Nucleosidos terapeuticos.
MD1051C2 (ro) Remediu antiherpetic
AR007983A1 (es) Formulacion
ES2190499T3 (es) Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer.
ITRM920351A0 (it) Formulazione farmaceutica per uso topico, indicata nel trattamento di infezioni virali della pelle e delle mucose.
BR9810930A (pt) Composições farmacêuticas de arglabina e derivados de arglabina
ITGE940025A0 (it) Preparazione farmaceutica ad uso topico per la cura della psoriasi e di altre dermatosi.
IT1242000B (it) Impiego di sali di trometamina in composizioni farmaceutiche a base di calcitonina somministrabili per via nasale in terapia umana.
MC2450A1 (fr) Composition pour le traitement topique d'affections de la peau et des phanères
MX9203715A (es) Preparciones para el tratamiento del tejido aloinjertado.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930421

FG3A Patent granted, date of granting

Effective date: 19990415

PC3A Transfer or assignment

Free format text: 20011016 NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. BM

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20140415